RUA Life Sciences (LON:RUA) Trading Up 2.1% – Still a Buy?

RUA Life Sciences plc (LON:RUA) shares were up 2.1% during mid-day trading on Monday . The stock traded as high as GBX 12 ($0.15) and last traded at GBX 12 ($0.15). Approximately 25,432 shares were traded during trading, a decline of 90% from the average daily volume of 243,376 shares. The stock had previously closed at GBX 11.75 ($0.15).

RUA Life Sciences Stock Performance

The stock has a market cap of £7.45 million, a price-to-earnings ratio of -300.00 and a beta of 1.21. The firm has a fifty day simple moving average of GBX 11.35 and a 200 day simple moving average of GBX 11.66. The company has a current ratio of 9.01, a quick ratio of 7.32 and a debt-to-equity ratio of 5.42.

RUA Life Sciences (LON:RUA) last issued its earnings results on Wednesday, December 11th. The company reported GBX 1.03 ($0.01) EPS for the quarter. RUA Life Sciences had a negative return on equity of 24.27% and a negative net margin of 65.72%.

RUA Life Sciences Company Profile

The RUA Life Sciences group was created in April 2020 when AorTech International plc acquired RUA Medical Devices Ltd to create a fully formed medical device business. RUA Life Sciences is the holding company of the group trading through four businesses all exploiting the group’s polymer technology. Our vision is to improve the lives of millions of patients by improving and enabling medical devices with Elast-EonTM, the worlds leading long term implantable polyurethane.